SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Director/PDMR Shareholding

28 Jun 2019 11:30

RNS Number : 8425D
Porvair PLC
28 June 2019
 

 

Porvair plc ("Porvair" or the "Company")

Director's Shareholding

The Company was notified on 27 June 2019 of the following exercises of Long Term Share Plan Share options ("LTSP") over ordinary shares of 2 pence each in the Company ("Ordinary Shares").

Director

Scheme

Year of grant

Exercise price

Options exercised

Ben Stocks

LTSP

2016

2.0p

96,700

Chris Tyler

LTSP

2016

2.0p

67,900

On the same day, the Company was notified that Ben Stocks, Group CEO, and Chris Tyler, Group Finance Director, had sold the following Ordinary Shares in order to meet the cost of exercise, the personal taxation liabilities arising on the options and certain other financial commitments.

Director

Transaction

Price

Number

Ben Stocks

Sale

£5.82

76,700

Chris Tyler

Sale

£5.82

52,900

The Company was also notified on 27 June 2019 of the following purchase on 7 June 2019 by Ben Stocks of Ordinary Shares pursuant to the Group's dividend reinvestment plan ("DRIP").

Director

Transaction

Price

Number

Ben Stocks

DRIP purchase

£5.68

3,513

Following these dealings, Ben Stocks' holding in the Company has increased by 23,513 Ordinary Shares to 762,933 Ordinary Shares, representing approximately 1.7 per cent. of the Company's issued share capital. Chris Tyler's holding in the Company has increased by 15,000 Ordinary Shares to 494,311 Ordinary Shares, representing approximately 1.1 per cent. of the Company's issued share capital.

As at today's date, the total number of voting rights in the Company is 45,843,599. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Porvair plc

01553 765 500

Chris Tyler, Group Finance Director

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Christopher Tyler

2.

Reason for the notification

a.

Position/status

CFO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary shares of 2p

 

 

GB0006963689

b.

Nature of the transaction

 

1) Exercise of LTSP share options

 

2) Sale of ordinary shares

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1)

£0.02

67,900

2)

£5.82

52,900

d.

Aggregated information

· Aggregated volume

· Price

 

 

As above

e.

Date of the transaction

27 June 2019

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Ben Stocks

2.

Reason for the notification

a.

Position/status

CEO

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Porvair plc

b.

LEI

213800ECKHS8LAQO3C45

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary shares of 2p

 

 

GB0006963689

b.

Nature of the transaction

 

1) Exercise of LTSP share options

 

2) Sale of ordinary shares

 

3) Purchase of shares through the dividend reinvestment plan

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1)

£0.02

96,700

2)

£5.82

76,700

3)

£5.68

3,513

d.

Aggregated information

· Aggregated volume

· Price

 

 

As above

e.

Date of the transaction

27 June 2019

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZMGZVGRKGLZM
Date   Source Headline
27th Mar 20257:00 amRNSGrant of SAYE Options
18th Mar 20257:40 amRNSHolding(s) in Company
17th Mar 20253:30 pmRNSHolding(s) in Company
14th Mar 20257:00 amRNSNotice of Annual General Meeting; Accounts posting
4th Mar 20253:00 pmRNSHolding(s) in Company
12th Feb 20252:30 pmRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSFull Year Results
12th Dec 20241:00 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTrading update and notice of results
2nd Dec 20243:01 pmRNSTotal Voting Rights
2nd Dec 20243:00 pmRNSDirector/PDMR Shareholding
25th Nov 20244:37 pmRNSShareholder Communications
28th Oct 20247:00 amRNSBoard appointment
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSAppointment of Chief Executive Officer
2nd Sep 20245:15 pmRNSDirector/PDMR Shareholding
2nd Sep 20245:00 pmRNSTotal Voting Rights
31st Jul 202410:45 amRNSTotal Voting Rights
31st Jul 202410:30 amRNSBlock listing Interim Review
29th Jul 20246:15 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSInterim Results
27th Jun 20242:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.